Search results
S2.2.2-12,S2.2.2-13 In CAST (Cardiac Arrhythmia Suppression Trials), treatment of patients with post-myocardial infarction (MI) who took antiarrhythmic medications (eg, flecainide, encainide, moricizine) increased the risk of death despite suppression of VA.
- Circulation
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Pulseless Electric Activity
Electric mechanisms associated with SCA are broadly...
- View PDF
e272 September 25, 2018 Circulation. 2018;138:e272–e391....
- Robert J. Myerburg
Background—Coronary artery disease is identified in ≈80% of...
- Figure 1E
The onset and maintenance of cardiac fibrillation require an...
- A Nationwide Study in Denmark
BackgroundWe aimed to investigate the incidence and risk...
- Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports
Since the 2004 update, there has been a substantial increase...
- Lifetime Risk for Sudden Cardiac Death in The Community
We present the first lifetime risk estimates for SCD.Greater...
- Circulation
26 sie 2022 · In case of a known idiopathic VT (Figure 4), treatment with beta-blockers (for RVOT VT) 306 or verapamil (for fascicular VT) 307 is recommended for acute conversion. Although verapamil may terminate other types of idiopathic VT, 307 important adverse effects such as severe hypotension may occur.
26 sie 2022 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Ventricular Arrhythmias and the Prevention of Sudden Cardiac (SCD).
Comparison of recommendations regarding the treatment of patients with idiopathic premature ventricular contractions and idiopathic ventricular tachycardia according to 2022 ESC and 2017 AHA/ACC/HRS Guidelines (mentioned in the Table as AHA).
The purpose of the guideline is to provide a contemporary guideline for the management of adults who have ventricular arrhythmias (VA) or who are at risk for sudden cardiac death (SCD), including diseases and syndromes associated with a risk of SCD from VA.
21 paź 2022 · 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43 (40):3997-4126. doi: 10.1093/eurheartj/ehac262. Authors.
2 wrz 2022 · Catheter ablation as first-line treatment is recommended for symptomatic idiopathic VT and premature ventricular contractions (PVCs) from the right ventricular outflow tract (RVOT) or the left fascicles.
